Roflumilast for the treatment of diabetes mellitus

Roflumilast for the treatment of diabetes mellitus

The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kley, Hans-Peter, Hanauer, Guido, Hauser, Daniela, Schmidt, Beate, Bredenbroeker, Dirk, Wurst, Wilhelm, Kemkowski, Joerg
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Kley, Hans-Peter
Hanauer, Guido
Hauser, Daniela
Schmidt, Beate
Bredenbroeker, Dirk
Wurst, Wilhelm
Kemkowski, Joerg
description The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08017633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08017633</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080176333</originalsourceid><addsrcrecordid>eNrjZDAKyk_LKc3NzEksLlFIyy9SKMlIVSgpSk0syU3NK1HIT1NIyUxMSi1JLVbITc3JySwpLeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAXcXx6UWJIMrAwsDQ3MzY2JgIJQC6Ii0y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Roflumilast for the treatment of diabetes mellitus</title><source>USPTO Issued Patents</source><creator>Kley, Hans-Peter ; Hanauer, Guido ; Hauser, Daniela ; Schmidt, Beate ; Bredenbroeker, Dirk ; Wurst, Wilhelm ; Kemkowski, Joerg</creator><creatorcontrib>Kley, Hans-Peter ; Hanauer, Guido ; Hauser, Daniela ; Schmidt, Beate ; Bredenbroeker, Dirk ; Wurst, Wilhelm ; Kemkowski, Joerg ; Nycomed GmbH</creatorcontrib><description>The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8017633$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8017633$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kley, Hans-Peter</creatorcontrib><creatorcontrib>Hanauer, Guido</creatorcontrib><creatorcontrib>Hauser, Daniela</creatorcontrib><creatorcontrib>Schmidt, Beate</creatorcontrib><creatorcontrib>Bredenbroeker, Dirk</creatorcontrib><creatorcontrib>Wurst, Wilhelm</creatorcontrib><creatorcontrib>Kemkowski, Joerg</creatorcontrib><creatorcontrib>Nycomed GmbH</creatorcontrib><title>Roflumilast for the treatment of diabetes mellitus</title><description>The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAKyk_LKc3NzEksLlFIyy9SKMlIVSgpSk0syU3NK1HIT1NIyUxMSi1JLVbITc3JySwpLeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAXcXx6UWJIMrAwsDQ3MzY2JgIJQC6Ii0y</recordid><startdate>20110913</startdate><enddate>20110913</enddate><creator>Kley, Hans-Peter</creator><creator>Hanauer, Guido</creator><creator>Hauser, Daniela</creator><creator>Schmidt, Beate</creator><creator>Bredenbroeker, Dirk</creator><creator>Wurst, Wilhelm</creator><creator>Kemkowski, Joerg</creator><scope>EFH</scope></search><sort><creationdate>20110913</creationdate><title>Roflumilast for the treatment of diabetes mellitus</title><author>Kley, Hans-Peter ; Hanauer, Guido ; Hauser, Daniela ; Schmidt, Beate ; Bredenbroeker, Dirk ; Wurst, Wilhelm ; Kemkowski, Joerg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080176333</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kley, Hans-Peter</creatorcontrib><creatorcontrib>Hanauer, Guido</creatorcontrib><creatorcontrib>Hauser, Daniela</creatorcontrib><creatorcontrib>Schmidt, Beate</creatorcontrib><creatorcontrib>Bredenbroeker, Dirk</creatorcontrib><creatorcontrib>Wurst, Wilhelm</creatorcontrib><creatorcontrib>Kemkowski, Joerg</creatorcontrib><creatorcontrib>Nycomed GmbH</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kley, Hans-Peter</au><au>Hanauer, Guido</au><au>Hauser, Daniela</au><au>Schmidt, Beate</au><au>Bredenbroeker, Dirk</au><au>Wurst, Wilhelm</au><au>Kemkowski, Joerg</au><aucorp>Nycomed GmbH</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Roflumilast for the treatment of diabetes mellitus</title><date>2011-09-13</date><risdate>2011</risdate><abstract>The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agents for the treatment of diabetes mellitus.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08017633
source USPTO Issued Patents
title Roflumilast for the treatment of diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A36%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kley,%20Hans-Peter&rft.aucorp=Nycomed%20GmbH&rft.date=2011-09-13&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08017633%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true